CeVD Study
An investigation of the utility of non-invasive transcranial Doppler (TCD) ultrasound in the prediction of moyamoya disease in persons with Down syndrome with the goal of identifying cerebrovascular disease before it causes a stroke.
Find a Research Study
Displaying 1 - 3 of 3
DSRD Clinical Trial
The first Phase IIb clinical trial in Down syndrome regression disorder (DSRD). An open-label, randomized study comparing the safety and efficacy of lorazepam, intravenous immunoglobulin (IVIg) and the Janus Kinase inhibitor (JAK inhibitor), tofacitinib.
Non-Invasive Screening for Cerebrovascular Disease in Down Syndrome
To investigate if non-invasive screening for cerebrovascular diseases in persons with Down syndrome is feasible with the goal of preventing stroke.